Clear.bio

Clear.bio is a healthtech startup, established in 2019 and headquartered in The Netherlands. Founded by Piet Hein van Dam and Madelon Bracke, the company is on a mission to revolutionize the management of type 2 diabetes by leveraging data and cutting-edge technology. Their vision, encapsulated in the slogan, “We want to help billions of people with type 2 diabetes to become the best and healthiest version of themselves." focuses on a personalized, data-driven approach to nutrition over traditional medication.

Clear.bio introduces an innovative digital self-help tool that utilizes real-time blood sugar monitoring via a sensor and app combination, guiding users in making optimal dietary choices. This method underscores the importance of understanding individual metabolic responses to food, paving the way for concrete, personalized advice.

Backed by investors like Antler, Healthy.Capital, Future Food Fund, MSM, Achmea Innovation Fund, and Horizon Flevoland, Clear.bio secured its most recent investment during a Venture Round on 09 November 2022. The company's dedication to transforming diabetes care positions it as a compelling opportunity for investors aligned with health innovation and personalized medicine.